Literature DB >> 3944768

In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.

R A Giuliano, G A Verpooten, L Verbist, R P Wedeen, M E De Broe.   

Abstract

The renal cortical uptake kinetics of four aminoglycosides were studied in vivo. Gentamicin, netilmicin, tobramycin or amikacin were administered to rats by continuous infusion over 6 hr achieving constant serum levels ranging from 0.2 to 100 micrograms/ml. Renal cortical concentrations at the end of the infusion were plotted against the steady-state serum levels. Steady-state elevations of serum gentamicin and netilmicin were associated with nonlinear increases in cortical levels, suggesting saturable uptake. Analysis of the data using Michaelis-Menten kinetics indicates that the apparent Km for gentamicin and netilmicin were 15.01 and 23.84 micrograms/ml and Vmax 149.83 and 178.36 micrograms/g of cortex per hr, respectively. The "initial" rate of uptake (at serum levels below 15 micrograms/ml) was highest for gentamicin. The cortical uptake of tobramycin was linearly related to elevations in serum levels [cortex concentration (conc) = 9.24 + 1.40 serum conc]. The initial rate of tobramycin uptake was considerably lower than that for gentamicin and netilmicin. For amikacin, the initial rate of uptake followed Michaelis Menten kinetics and the second phase of the titration curve was linear. The equation for total amikacin uptake was: cortex conc = 12.98 + 1.71 serum conc. Aminoglycosides exhibit differing kinetics for renal cortical uptake in the rat during constant infusions. These results indicate that more than one mechanism probably mediates the uptake of each aminoglycoside. Depending on which mechanism predominates, the kinetic pattern may be saturable, linear or mixed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944768

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  43 in total

1.  A physiologically based pharmacokinetic model for capreomycin.

Authors:  B Reisfeld; C P Metzler; M A Lyons; A N Mayeno; E J Brooks; M A Degroote
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Effect of dextran sulfate on renal accumulation of gentamicin.

Authors:  S Kikuchi; Y Aramaki; H Nonaka; S Tsuchiya
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

3.  Effect of isepamicin dosing scheme on concentration in cochlear tissue.

Authors:  P J Govaerts; J Claes; P H Van de Heyning; M P Derde; L Kaufman; J F Marquet; M E De Broe
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Once-daily dosing of aminoglycosides.

Authors:  J Blaser; C König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

5.  Effect of age on the intracortical accumulation kinetics of gentamicin in rats.

Authors:  D Beauchamp; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  Aminoglycoside dosages and nephrotoxicity: quantitative relationships.

Authors:  Florent Rougier; Michel Ducher; Michel Maurin; Stéphane Corvaisier; Daniel Claude; Roger Jelliffe; Pascal Maire
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis.

Authors:  Stefanie Hennig; Joseph F Standing; Christine E Staatz; Alison H Thomson
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

8.  Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats.

Authors:  D Tardif; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 9.  Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis.

Authors:  Andrew Prayle; Alan Watson; Heather Fortnum; Alan Smyth
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

Review 10.  Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries.

Authors:  Gary L Darmstadt; Mary Miller-Bell; Maneesh Batra; Paul Law; Kiely Law
Journal:  J Health Popul Nutr       Date:  2008-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.